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We describe a simple, reproducible, discontinuous system for polyacrylamide disc gel-electrophoresis, with which the alkaline phosphatase isoenzymes in human serum can be fractionated.
No sample preparation is needed. The isoenzymes are classified according to their electrophoretic mobilities (RF values) and quantitated by peak area measurements from spectrophotometnc scans. The four alkaline phosphatase isoenzymes usually present in normal sera, in order of descending mobilities (and designated according to principal tissue of origin) are: 'fast" liver, 'slow" liver, bone, and intestine. Sera of diseased patients show a greater variety of isoenzyme distribution patterns, but the most frequently observed patterns are the same as normal patterns. We conclude that the finding of "fast" liver only is not pathognomonic, as previously reported by others, and that information on relative distributions per se is not diagnostically useful, although information on specific increases in activity is useful. With this system, hepatobiliary disorders can be differentiated from other forms of liver and bone diseases. Alkaline phosphatase (orthophosphoric monoester phosphohydrolase, EC 3.1.3.1) in human serum appears to originate from the hepatobiliary system, bone, intestine, placenta, and other tissues. In many patients the tissue source of an increased activity of alkaline phosphatase in serum may not be readily apparent from clinical and laboratory findings. Because alkaline phosphatase isoenzymes present complex patterns on electrophoresis, several methods
(1-8)
have been described for fractionating them, as the first step in demonstrating their origin.
A disadvantage of most electrophoretic procedures
is the incomplete separation of phosphatases that originate from liver and bone. Heat inactivation, now used in many laboratories to assess isoenzyme origin, has a serious disadvantage:
rates of heat denaturation change markedly with small variations in temperature (9).
Here, we report a reproducible method for using a discontinuous buffer system and polyacrylamide disc gel for the electrophoretic separation and quantitation of human serum alkaline phosphatase isoenzymes in normal serum and in serum from persons with various disorders.
Materials and Methods

Samples
Preparation of tissue markers.
Fresh tissues, obtained at autopsy, were extracted according to the modified (2) method of Morton (10).Total alkaline phosphatase activity of the extracts and sera was determined by the method of Bowers and McComb (11).
Sera. Blood samples were obtained by venipuncture from 40 fasting,healthy men and women (hospital employees).
The normal range of total alkaline phosphatase activity was 27-91 U/liter. Sera of hospitalized patients with high total alkaline phosphatase activity were selected for study. Diagnoses in these abnormal cases were verified retrospectively by the clinical and laboratory data available in their medical records.
Ion-free serum (Chemvarion; Clinton Laboratories, Santa Monica, Calif. 90404) with a residual alkaline phosphatase activityof 15 U/literwas used as a diluent for tissue extracts.
Reagents
Acrylamide gel monomer. Acrylamide (Eastman Kodak Co., Rochester, N. V. 14650), 20 g, and N,N'-methylene-bisacrylamide (BIS; Eastman), 0.68 g, were dissolved in 100 ml of water.
Tris-HC1 gel buffer, pH 8.9 (25 #{176}C). This reagent was made by adding 18.15 g of tris(hydroxymethyl)-aminomethane, and 0.40 ml of N,N,N',N'-tetraethylethylenediamine (TEMED; Eastman) to 50 ml of water, titrating to pH 8.9 with 1 mol/liter HC1, and dilutingto 100 ml. The running gel was prepared by mixing the monomer, gel buffer, and ammonium persulfate in a 1:1:2 ratio by volume. The mixture was pipetted into 0.5 X 10 cm gel tubes and then overlayered with 50 pl of water. Polymerization was complete within 15-20 mm at 4 #{176}C. Gels could be stored in the refrigerator for a week in a moist container iftheir top surfaces were covered with water. Sera with higher activity were diluted with sucrose so that the activity was decreased to 30-90 U/liter, and 25-50 pl was applied to the top of the running gel. Within these limits, the volume of serum used did not affect the mobilities of the various zones. Electrophoresis was done at 4 #{176}C in a disc electrophoresis apparatus (Savant Instruments Inc., Hicksville, N. V. 11801), with use of the running gel. Just enough bromphenol blue (Allied Chemical Corp., New York, N. Y. 10006) was added to the upper reservoir to serve as a visual marker of progress.A current of 2 mA per tube (90 V) was applied until the bromphenol blue marker had entered the gel; the current was then increased to a constant 4 mA per tube (300 V) for the rest of the run. When the bromphenol blue/albumin front was about 2 cm from the bottom of the gel (about 1 h) the electrophoresis was stopped. The gels were immediately removed from the tubes by gently rimming with a 22-gauge needle and cut at the bromphenol blue/albumin front so that the Rp (the ratio between the distance traveled by a protein and the distance traveled by the bromphenol blue/albumin front) could be measured. Extracts of human liver, bone, and small intestine were mixed with the ion-free serum and used as primary references.
Ammonium
Visualization
of Alkaline Phosphatase lsoenzyme Activity
The alkaline phosphatase isoenzyme activity was localized as follows. The gels were incubated at 37 #{176}C for 10 mm in a freshly prepared aqueous reaction mixture of fl-naphthyl phosphate (Sigma Chemical Co., St. Louis, Mo. 63178) 2 mg/mI, and MgSO4, 1 mg/ml. In this step, timing is critical and must not exceed 10 mm; longer incubation results in diffusion of the liberated -naphthyl and consequent smearing of isoenzyme bands.
The substrate solution was then decanted and the reaction product released by the enzyme within the gel was coupled to an aqueous solution of 1 mg/ml Fast Blue RR (Sigma) at 37 #{176}C for 15-20 mm, producing purple bands. The staining reaction was stopped by immersing the gels in dilute acetic acid (50 ml/liter), in which the gels were also then washed and stored.
Experiments on Organ-Specific Inhibitors
As an aid to identifying the liver, bone, and intestinal alkaline phosphatase isoenzymes, we added the organ-specific inhibitors L-phenylalanine (2 mmol/ liter) or L-homoarginine (10 mmol/liter) to the substrate incubation reaction mixture before the coupler was added, according to the method of Green et al.
L-homoarginine specifically inhibits the liver and bone isoenzymes.
Characterization and Quantitation
The developed gels were scanned at 1 cm/mm in a Model 240 spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio 44074) equipped with a linear gel transport adaptor.
The alkaline phosphatase isoenzymes were identified by RF measurements. The areas under each peak were calculated, to determine the relative activity of each of the isoenzymes present.
Results
Specimen Preservation
During the investigation we found that some recombination of the liver and bone isoenzyme bands occurred if the specimens were kept at 4 #{176}C or -20 #{176}C for six to seven days. A small amount of alkaline phosphatase activity could be detected at the origin after the specimen was frozen and thawed, and repeated freezing and thawing affected all isoenzyme bands similarly.
This may be due to an intramolecular rearrangement that reverses a partial denaturation and loss of enzyme activity on freezing (12). To eliminate artifacts, we stored the specimens at room temperature and used them for isoenzyme electrophoresis within a day or two.
Reproducibility
The within-run reproducibility of the method in the normal range was studied by serial analysis of sera containing the liver and bone isoenzymes. In a series of 10 analyses for these two isoenzymes, the RF values were, respectively, 0.55 ± 0.03 (CV = 0.6%) and 0.50 ± 0.08 (CV = 1.7%), with CV's for calculated peak areas of 9.9% and 1.5%. fast' and 'slow' liver isoenzymes, respectively; peak 3. isoenzyme of intestinal origin; peaks 4 and 5, 'fast" and slow" high-molecular-weight alkaline phosphatase lsoenzymes, respectively. Studies with organ-specific inhibitors (L-phenylalanine, L-homoarginine, or heat) were made of serum and tissue homogenates simultaneously, to establish the identities of each isoenzyme. While both the fast-moving band (L) and the diffuse band (B) were inhibited by L-homoarginine, only the B band was completely inactivated when heated at 56 #{176}C for 10 mm. L-Phenylalanine, on the other hand, had no effect on either of these isoenzymes, but caused considerable inhibition of the slow-moving isoenzyme band (I), which was heat-stable and more active after the subject had had a heavy meal. These inhibition and inactivation tests confirmed our findings with tissue extracts: the fast-moving band was evidently of liver origin, the second of bone, and the more cathodal one of intestinal origin. Spectrophotometric scans of normal serum alkaline phosphatase isoenzyme patterns are shown in Figure 3 a, b , and c. The identity of each isoenzyme band was established by measuring the RF value of each peak from the scan. Although there had appeared to be only one fast-moving band, RF measurements from scans (as in Figure 3c ) confirmed that there were two distinct entities with slight difference in mobility.
In 12.5% of the normal sera, only the In 35%, a couplet of "liver" bands appeared, both similarly sensitive to Lhomoarginine inhibition and not appreciably inactivated. by heating at 56 #{176}C for 10 mm. The slightly faster band had an RF value of 0.60-0.65 (peak 1) while the slower component of the couplet had an RF value of 0.55-0.59 (peak 2). Peak 3 was inhibited by L-phenylalanine and was evidently of intestinal origin.
Human bile (from autopsy) was studied for parallelism with the "fast" liver activity and was found to contain three alkaline phosphatase isoenzymes (peaks A, B, and C, Figure 4 ) on polyacrylamide gel, with RF values of 0.60, 0.40, and 0.11, respectively. All of these isoenzyme bands were sensitive to Lhomoarginine inhibition. Some precipitated material, possibly high-molecular-weight aggregates of alkaline phosphatase, was stained at the origin. When the bile was centrifuged (5000 X g, 4 #{176}C, 10 mm) and the supernate taken for electrophoresis, only peak A, with an RF of 0.61, was present in the gel. We postulated that peaks B and C were bile-salt complexes of alkaline phosphatase, which had settled with the precipitate when the bile was centrifuged.
It seems likely, therefore, that the "fast" liver component in normal serum originates from bile.
Finally, a small alkaline phosphatase activity was present in the fl-globulin region in 25% of normal sera. Two different bands were observed, with RF values of 0.12 to 0.26 and 0.15 to 0.19, respectively ( Table  1) . The highest observed concentration of these activities, summed, was 5% of the specimen's total. No sex, age, dietary, specimen handling, electrophoretic, or staining factors were identified to account for their presence, and no clinical significance could be associated with them. Their electrophoretic mobilities are consistent with the postulate that they may be lipoprotein-linked complexes. The distribution and frequency of various alkaline phosphatases in normal human sera are shown in Table 2 and Figure 5 . At least seven isoenzyme patterns appear. The first pattern listed in the table has only "fast" liver, while the fourth has only "slow," and the sera with these patterns appear as separate entities in Figure 5 (A and B) , suggesting separate populations.
All other patterns are combinations of more than one isoenzyme, and in these, liver-type isoenzyme activity is either predominant or nearly equal to the next most active band. No placental alkaline phosphatase band was present in any of this group.
Total alkaline phosphatase activity (U/liter) measured by the Bowers and McComb method (11).
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Alkaline Phosphatase lsoenzyme Profiles in Pathological Sera
Patients were grouped according to the serum isoenzyme patterns (Table  3) . Six patterns were observed in this study, three with only one isoenzyme type and three with mixed multiple banding. The "slow" liver isoenzyme was seen in two of these mixed multiple-banding patterns.
In pathological states involving the hepatobiliary system, only the "fast" liver band was increased. In other types of liver disease, the "slow" liver isoenzyme activity was increased.
Bone isoenzyme activity was increased in various types of diseases in children, but the normal distribution in children was not studied. Activity of the intestinal alkaline phosphatase isoenzyme was increased in the serum of only one patient, with cirrhosis.
Discussion
Abnormally high serum alkaline phosphatase activities frequently indicate liver or bone disease, although normal and abnormal sera contain a variety of isoenzyme patterns.
We were able to fractionate the isoenzymes reproducibly on polyacrylamide disc gels by using a discontinuous electrophoretic buffer system. Seven of the abnormals, but no normals, showed bone isoenzyme only, although a larger normal study might have detected such a group. Alternatively, the abnormal sera in the bone-only grouping may contain normal concentrations of liver or intestinal activities, but these were present below the limit of staining sensitivity when small aliquots of sera were electrophoresed.
In the other single-band patterns, only the "fast" or the "slow" liver isoenzymes were observed in both normal and abnormal specimens. A larger study might also indicate several sub-populations, substantiating the numerous publications dealing with genetic variation of alkaline phosphatase activity. The occurrence of only one isoenzyme in normal serum is more common in this study than in other reports (e.g., 3, 5). Rhone and Mizuno (5) observed the pattern with only "slow" liver activity in one of 30 normals studied, but excluded it from a table and reported only two patterns for normal sera. Technical differences may account for the smaller variety and lower frequency of band pattern distribution for normal and pathological sera reported in the earlier studies. Because of the pattern diversity in both normal and pathological sera reported here, relative distribution of alkaline phosphatase isoenzymes as such would not seem to have diagnostic significance if reported as either percentage or ratios. Examination of the data relative to elevations of specific isoenzyme activity is more fruitful.
The predominance of hepatic isoenzymes in normal sera is well documented. Separation of this liver activity into "fast" and "slow" components, however, was not possible by most earlier methods, and it is a good indicator of method sensitivity. Using a different supporting electrophoretic media, others (7) have observed the presence of a "fast" liver band migrating in the ai-globulin region in clinically healthy people. Rhone et al. (5, 13) claimed that the "fast" liver isoenzyme is found only in pathological conditions, and suggested that the faster liver band was related to hepatobiliary involvement and probably represents bile isoenzyme regurgitated into the sinusoids in cases of obstruction with increased total alkaline phosphatase activity (14-16).
The abnormal cases having increased "fast" liver enzyme activity studied here involve biliary obstruction and tend to confirm the above hypothesis.
Sera of children and of patients with bone diseases contain a bone isoenzyme with identical electrophoretic mobility.
In Table 3 ). The relatively low incidence of this isoenzyme in the serum of patients with various gastrointestinal disorders such as ulcerative colitis or gastric ulcers is interesting and suggests either that the intestinal mucosa may not release much phosphatase into the circulation in these conditions or that the enzyme is selectively inactivated if released. Similarly, the absence of serum activity with kidney alkaline phosphatase mobility indicates that this isoenzyme has distinctive mechanisms for circulatory release, inhibition, or destruction. A disadvantage of our method, its inability to discriminate the "slow" liver fraction from placental or Regan isoenzymes, may be resolved by heating the serum samples at 65 #{176}C for 10 mm before electrophoresis, because only the Regan isoenzymes will be detected after this treatment.
Heat denaturation was not routinely performed to differentiate these isoenzymes because we did not anticipate the high incidence of cancer-related increases in alkaline phosphatase (of the 16 cases with abnormal "slow" liver band activities, 11, or 69%, had cancer in some form).
In several ways, our method is an improvement over other techniques for separating alkaline phosphatase isoenzymes by polyacrylamide gel electrophoresis. The sera in our study did not contain nonmigrating, non-quantitatable enzyme activities. The isoenzymes migrate into the gel as distinct entities, which can be identified readily. The system is sensitive enough to resolve and detect both of the liver components in either normal or abnormal serum. The quantitation technique is reproducible and was of demonstrable value in studying normal and pathological sera The reproducibility of isoenzyme RF values ensures that "fast" and "slow" liver activities are easily distinguished.
A greater distribution of isoenzymes in normal and pathological sera is detected with this method. 
